AusPAR: Fluticasone propionate / Eformoterol fumarate dihydrate

Australian Public Assessment Report

AusPAR

AusPAR: Fluticasone propionate / eformoterol fumarate dihydrate [PDF, 3.18 MB]

AusPAR: Fluticasone propionate / eformoterol fumarate dihydrate [Word, 2.76 MB]

Attachment: Product Information: Fluticasone propionate / eformoterol fumarate dihydrate [PDF, 273.27 KB]

Attachment: Product Information: Fluticasone propionate / eformoterol fumarate dihydrate [Word, 200.65 KB]

Attachment: Extract from Clinical Evaluation Report: Fluticasone propionate / eformoterol fumarate dihydrate [PDF, 6.09 MB]

Attachment: Extract from Clinical Evaluation Report: Fluticasone propionate / eformoterol fumarate dihydrate [Word, 7.52 MB]

Device/Product Name

Flutiform

Active ingredients

Fluticasone propionate / Eformoterol fumarate dihydrate

AusPAR Date

13 June 2013

Published

17 September 2013

Submission Number

PM-2010-03251-3-5

Submission Type

New combination of active ingredients

Decision

Approved